FDA WARNING_LETTER - vapingland.com - October 01, 2025

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to vapingland.com on October 1, 2025, following a review of their website. The FDA determined that vapingland.com is offering for sale or distribution in the United States electronic nicotine delivery system (ENDS) products, which are considered tobacco products under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

The primary violation involves the marketing of a "new tobacco product," specifically "Airfuze Addon 40K Disposable Vape – Winter Mint (Ice Control) Addon w/ Nicotine Strip," without the necessary premarket authorization order from the FDA. Under the FD&C Act, new tobacco products require such authorization to be legally marketed in the U.S., a requirement the company failed to meet for the identified product. This renders the product both "adulterated" and "misbranded" according to FDA regulations. The regulatory framework cited includes sections of the FD&C Act that define tobacco products and mandate premarket authorization for new products.

vapingland.com is required to take prompt action to address these violations. The FDA demands a written response within 15 working days from the letter"s receipt, detailing the specific actions taken to discontinue the violative sale and distribution of these products, and outlining a plan to ensure ongoing compliance with the FD&C Act. Failure to comply may result in further regulatory actions, including civil money penalties or seizure.